http://rdf.ncbi.nlm.nih.gov/pubchem/author/MD5_89cd4ab68d507b9bbb493670b590b2b1
Outgoing Links
| Predicate | Object |
|---|---|
| family-name | Germing |
| name | Ulrich Germing |
| given-name | Ulrich |
| organization-name | Department of Hematology, Oncology and Clinical Immunology Medical Faculty, Heinrich-Heine-University, Düsseldorf, Germany Department of Hematology, Oncology and Clinical Immunology, Medical Faculty, University of Duesseldorf, Duesseldorf, Germany Department of Hematology, Oncology, and Clinical Immunology, Heinrich-Heine-University, University Clinic, Düsseldorf, Germany Author affiliations appear at the end of this article. Department of Hematology, Oncology and Clinical Immunology University Hospital Duesseldorf, Medical Faculty, Heinrich Heine – University Duesseldorf Germany Department of Hematology, Oncology and Clinical Immunology, University of Duesseldorf, Medical Faculty, Düesseldorf, Germany. Department of Hematology, Oncology and Clinical Immunology, Universitätsklinik Düsseldorf, Düsseldorf, Germany; Department of Hematology, Oncology and Clinical Immunology Heinrich‐Heine‐University of Düsseldorf Düsseldorf Germany From the Departments of Hematology and Medicine, University of Pavia & Fondazione Istituto di Ricovero e Cura a Carattere Scientifico Policlinico San Matteo, Pavia, Italy; Departments of Hematology, Oncology, and Clinical Immunology and Human Genetics, Heinrich-Heine-University, Düsseldorf; and Department of Haematology, Oncology, and Clinical Immunology, St Johannes Hospital, Duisburg, Germany Department Hematology, Oncology and Clinical Immunology, Heinrich Heine University, Dusseldorf, Germany 11Department of Haematology, Oncology and Clinical Immunology, Universitätsklinik Düsseldorf, Düsseldorf, Germany 2Department of Hematology, Oncology, and Clinical Immunology, Heinrich-Heine University, Dusseldorf, Germany Department of Hematology, Oncology and Clinical Immunology, Heinrich-Heine-University, Düsseldorf, Germany; Department of Hematology Oncology, and Clinical Immunology, Heinrich Heine University Düsseldorf Germany The Dept. of Hematology, Oncology and Clinical Immunology, Heinrich-Heine-University, 40225 Düsseldorf, Germany Department of Hematology, Oncology and Clinical Immunology, Heinrich-Heine University, Duesseldorf, Germany From the Department of Hematology, Oncology, and Clinical Immunology, and Institute of Human Genetics, Heinrich-Heine-University, Duesseldorf, Germany Department of Hematology, Oncology and Clinical Immunology Heinrich‐Heine University Duesseldorf Germany Department of Hematology, Oncology, and Clinical Immunology Heinrich‐Heine‐University Düsseldorf Germany 3Department of Hematology, Heinrich Heine University, D-40225 Düsseldorf, Germany Universitätsklinikum Düsseldorf, Germany Department of Hematology, Oncology and Clinical Immunology, Heinrich Heine University Duesseldorf, Duesseldorf, Germany; Department of Haematology, Oncology and Clinical Immunology, Heinrich-Heine University Duesseldorf, Duesseldorf, Germany; Department of Hematology, Oncology and Clinical Immunology Heinrich‐Heine University Dusseldorf Germany From the Internal Medicine III, University of Ulm, Ulm; University of Freiburg Medical Center, Freiburg; Universitätsklinik Düsseldorf, Düsseldorf; Medizinische Klinik und Poliklinik III, University of Bonn, Bonn; Departments of Cell and Molecular Pathology and Hematology, Hemostasis, Oncology and Stem Cell Transplantation, Hannover Medical School, Hannover, Germany; Departments of Hematology and Trials and Statistics, Erasmus University Medical Center, Rotterdam; Haematology, University Medical Center,... Department of Hematology, Oncology and Clinical Immunology, University Hospital Düsseldorf, Düsseldorf, Germany; From the Dept of Hematology, Oncology, and Clinical Immunology, and Institute of Biochemistry, Heinrich-Heine-University, Düsseldorf, Germany. Department of Haematology, Oncology and Clinical Immunology University Hospital Düsseldorf Germany Department of Hematology, Oncology, and Clinical Immunology, Heinrich-Heine-University Düsseldorf, Düsseldorf, Germany Department for Hematology, Oncology and Clinical Immunology, University Hospital Duesseldorf, 40225 Düsseldorf, Germany From the University Hospital of Ulm, Ulm; German Cancer Research Center, Heidelberg; University Hospital, Technical University of Munich, Munich; Medical Clinic II, University Hospital of Kiel, Kiel; and Oncology and Clinical Immunology, University Hospital Düsseldorf, Düsseldorf, Germany. Department of Hematology, Oncology and Clinical Immunology, Universitätsklinikum Düsseldorf, Düsseldorf, Germany Department of Hematology, Oncology, and Clinical Immunology, University of Düsseldorf, Düsseldorf, Germany; 2Heinrich-Heine-Universität Düsseldorf, Klinik für Hämatologie, Onkologie und klinische Immunologie, Düsseldorf, Germany Department of Hematology, Oncology and Clinical Immunology, Medical Faculty and University Hospital Düsseldorf, Heinrich-Heine-University Düsseldorf, Düsseldorf, Germany Department of Hematology, Oncology and Clinical Immunology, University Hospital Düsseldorf, Düsseldorf, Germany Department of Hematology, Oncology and Clinical Immunology Heinrich Heine University Düsseldorf Germany Department of Haematology, Oncology, and Clinical Immunology, Heinrich-Heine-University, Düsseldorf, Germany; Faculty of Medicine, Heinrich-Heine University, Düsseldorf, Germany Department of Hematology Oncology and Clinical Immunology, University Hospital Düsseldorf Düsseldorf Germany Department of Hematology, Oncology, and Clinical Immunology, Heinrich Heine University Düsseldorf, Düsseldorf, Germany; Department of Hematology and Oncology University of Duesseldorf Germany Department of Haematology, Oncology and Clinical Immunology, Medical Faculty University Hospital Duesseldorf Duesseldorf Germany Jan Krönke, Richard F. Schlenk, Kai-Ole Jensen, Florian Tschürtz, Andrea Corbacioglu, Verena I. Gaidzik, Peter Paschka, Shiva Onken, Karina Eiwen, Marianne Habdank, Daniela Späth, Hartmut Döhner, and Konstanze Döhner, University Hospital of Ulm, Ulm; Michael Lübbert, University of Freiburg Medical Center, Freiburg; Mohammed Wattad, Evangelic Hospital Essen-Werden, Essen; Thomas Kindler, University Medical Center, Johannes Gutenberg University, Mainz; Helmut R. Salih, Eberhard Karls University, Tübingen;... Heinrich-Heine University, Düsseldorf, Germany Department of Hematology, University of Duesseldorf Oncology and Clinical Immunology Düsseldorf Germany Department of Hematology, Oncology and Clinical Immunology Heinrich-Heine-University Moorenstr. 5, 40225 Düsseldorf, Germany. germing@med.uni-duesseldorf.de Department of Hematology, Oncology and Clinical Immunology Medical Faculty, University of Duesseldorf Duesseldorf Germany Department of Hematology, Oncology and Clinical Immunology Heinrich‐Heine‐University 40225 Düsseldorf Germany University of Düsseldorf, Düsseldorf, Germany; and. Department of Hematology, Oncology and Clinical Immunology, Heinrich-Heine-University, Moorenstr. 5, 40225 Düsseldorf, Germany Department of Hematology, Oncology, and Clinical Immunology, Heinrich Heine University Düsseldorf, 40225 Düsseldorf, Germany University Hospital Düsseldorf, Heinrich-Heine-Universität, Düsseldorf, Germany; Sophie Park, Centre Hospitalier Universitaire (CHU) Grenoble Alpes, Université Grenoble Alpes, Grenoble; Jean-François Hamel and Sylvain Thépot, CHU d’Angers; Sylvain Thépot, Université d’Angers, Institut National de la Santé et de la Recherche Médicale, Unité 1232, and LabEx IGO, Angers; Andrea Toma, CHU Henri Mondor, Assistance Publique Hôpitaux de Paris (AP-HP), Université Paris-Est Créteil; Rosa Sapena and Pierre Fenaux, CHU Saint Louis, AP-HP, Université Paris X; François Dreyfus, CHU Cochin, AP-HP,... Department of Hematology, Oncology and Clinical Immunology Heinrich‐Heine University Düsseldorf Düsseldorf Germany Department of Hematology, Oncology and Clinical Immunology, Heinrich-Heine University, 40225 Duesseldorf, Germany Department of Hematology, Oncology and Clinical Immunology University Hospital of Düsseldorf Düsseldorf Germany Department of Hematology Oncology and Clinical Immunology Heinrich‐Heine Universitätsklinikum Düsseldorf Düsseldorf Germany Department of Hematology, Oncology and Clinical Immunology University Hospital Duesseldorf Medical Faculty Heinrich Heine – University Duesseldorf Germany Stefan Gröschel, Richard F. Schlenk, Jan Engelmann, Veronica Teleanu, Michael W.M. Kühn, Karina Eiwen, Konstanze Döhner, Hartmut Döhner, University Hospital Ulm, Ulm; Michael Lübbert, University of Freiburg Medical Center, Freiburg; Ulrich Germing, Heinrich-Heine-University of Düsseldorf, Düsseldorf; Ingo G.H. Schmidt-Wolf, University of Bonn, Bonn; Brigitte Schlegelberger, Jürgen Krauter, Arnold Ganser, Hannover Medical School, Hannover, Germany; Veronika Rockova, Claudia Erpelinck, Marije Havermans, H.... Department of Hematology, Oncology and Clinical Immunology Heinrich‐Heine‐University Düsseldorf Germany Department of Hematology, Oncology and Clinical Immunology, Heinrich-Heine University of Düsseldorf, Germany. germing@med.uni-duesseldorf.de Department of Hematology, Oncology and Clinical Immunology Heinrich‐Heine‐Universität Düsseldorf Germany Klinik für Hämatologie, Onkologie und klinische Immunologie, Universitätsklinik Düsseldorf. germing@med.uni-duesseldorf.de From the Albert Ludwigs University, Freiburg; University of Dresden, Dresden; St Johannes-Hospital, Duisburg, Duisburg; Heinrich-Heine-University, Düsseldorf; University Hospital Tübingen, Tübingen; University of Hannover, Hannover; Diakoniekrankenhaus Bremen, Bremen, Germany; European Organisation for Research and Treatment of Cancer Headquarters, Brussels; AZ St Jan, Brugge; University of Leuven, Leuven, Belgium; University Hospital Zagreb, Zagreb, Croatia; Radboud University Nijmegen Medical Center,... Medizinische Klinik A, Heinrich-Heine-Universität Düsseldorf, DE Department of Hematology, Oncology, and Clinical Immunology University Hospital Düsseldorf Düsseldorf Germany Verena I. Gaidzik, Peter Paschka, Daniela Späth, Marianne Habdank, Hartmut Döhner, Richard F. Schlenk, Lars Bullinger, and Konstanze Döhner, Universitätsklinikum Ulm, Ulm; Claus-Henning Köhne, Klinikum Oldenburg, Oldenburg; Ulrich Germing, Universitätsklinikum Düsseldorf, Düsseldorf; Marie von Lilienfeld-Toal, Universitätsklinikum Bonn, Bonn; Gerhard Held, Universitätsklinikum des Saarlandes, Homburg; Heinz-August Horst, Universitätsklinikum Schleswig-Holstein, Kiel; Detlef Haase, Universitätsklinikum... Department of Hematology, Oncology and Clinical Immunology Universitätsklinik Düsseldorf Düsseldorf Germany From the Division of Hematology, Department of Internal Medicine, Saitama Medical School, Saitama, Japan; the Department of Hematology, Oncology and Clinical Immunology, Heinrich-Heine-University, Düsseldorf, Germany; and the Department of Hematology, Molecular Medicine Unit, Atomic Bomb Disease Institute, Nagasaki University Graduate School of Biomedical Sciences, Nagasaki, Japan. Department of Hematology, Oncology and Clinical Immunology Heinrich‐Heine‐University Duesseldorf Germany Department of Hematology, Oncology and Clinical Immunology, Heinrich-Heine-University Duesseldorf, Duesseldorf, Germany; Department of Haematology, Oncology and Clinical Immunology, Universitätsklinik Düsseldorf, Düsseldorf, Germany. From Service d’Hématologie Séniors, Hôpital Saint-Louis, Assistance Publique–Hôpitaux de Paris and Université Paris 7, Paris (P.F., L.A.), Service des Maladies du Sang, Hôpital Huriez, Centre Hospitalier Universitaire (CHU) de Lille, Lille (B.Q.), the Department of Internal Medicine, CHU Toulouse, Institut Universitaire du Cancer de Toulouse, Toulouse (O.B.-R.), and Université Cote d’Azur, Département d’Hématologie Clinique, CHU Nice, Nice (T.C.) — all in France; Medical Clinic and Policlinic 1,... From the Department of Haematological Medicine, King's College London School of Medicine, London, United Kingdom; and Klinik für Hämatologie, Onkologie und Klinische Immunologie, Heinrich-Heine-Universität, Düsseldorf, Germany. University Clinic for Hematology and Oncology, Düsseldorf, Germany; Medical Faculty, Department of Hematology, Oncology and Clinical Immunology, Heinrich Heine University, University Hospital Düsseldorf, Düsseldorf, Germany Departments of Hematology, Oncology and Clinical Immunology and Departments of Hematology, Oncology and Clinical Immunology, Heinrich Heine University, Medical Faculty, University Hospital Düsseldorf, Düsseldorf, Germany Department of Hematology, Oncology and Clinical Immunology Medical Faculty University of Duesseldorf Duesseldorf Germany Heinrich Heine University, Düsseldorf, Germany; From the University of Goettingen, Goettingen; University of Duesseldorf, Duesseldorf; Johannes Hospital, Duisburg; University of Freiburg, Freiburg, Germany; British Columbia Cancer Agency, Vancouver, British Columbia, Canada; Medical University of Vienna; Hanusch Hospital, L. Boltzmann Institute for Leukemia Research; Medical University of Vienna, Vienna; Medical University of Innsbruck, Innsbruck; Elisabethinen Hospital, Linz, Austria; MD Anderson Cancer Center, Houston, TX; and Seattle Cancer Care... Department for Hematology, Immunology and Clinical Oncology, Heinrich-Heine-University Düsseldorf, 40225 Düsseldorf, Germany Heinrich-Heine University Hospital, Düsseldorf, Germany; Klinik für Hämatologie Onkologie und Klinische Immunologie Heinrich‐Heine‐Universität Düsseldorf Germany From the Department of Hematology, Oncology, and Clinical Immunology and the Institute of Genetics, Heinrich-Heine-University, Düsseldorf, Germany. Deutsche MDS-Studiengruppe, D-04103 Leipzig, Germany; Heinrich-Heine University Düsseldorf, Universitätsklinik Düsseldorf, Klinik für Hämatologie, Onkologie und Klinische Immunologie, Düsseldorf, Germany Onkologie und Klinische Immunologie, Klinik für Hämatologie, Heinrich-Heine-Universität Düsseldorf, Düsseldorf, Germany; and Department of Haematology, Oncology and Clinical Immunology Universitätsklinik Düsseldorf Düsseldorf Germany †Department of Hematology, Oncology and Clinical Immunology, Heinrich-Heine University Düsseldorf, 40225 Düsseldorf, Germany; Correspondence: Ulrich Germing, Department of Hematology, Oncology and Clinical Immunology, Heinrich-Heine-University, Moorenstr 5, 40225 Düsseldorf, Germany; e-mail: Klinik für Hämatologie, Onkologie und Klinische Immunologie, Universitätsklinikum Düsseldorf, Heinrich-Heine Universität Düsseldorf, Germany Department of Hematology, Oncology and Clinical Immunology, Heinrich Heine University, Düsseldorf, Germany; Klinik für Hämatologie, Onkologie and Klinische lmmunologie, Universitätsklinik Düsseldorf, Heinrich-Heine-Universität, Düsseldorf, Germany 1Department of Hematology, Oncology and Clinical Immunology, Heinrich Heine University Düsseldorf, Düsseldorf, Germany From the Avicenne, Assistance Publique-Hôpitaux de Paris (AP-HP), Université Paris XIII, Bobigny; Hôpital Saint-Louis, AP-HP, Université Paris 7, Paris, France; King's College Hospital, London, United Kingdom; Karolinska University Hospital (Huddinge), Stockholm, Sweden; Azienda Ospedaliera Universitaria Careggi, Florence, Italy; Universitätsklinikum Düsseldorf, Düsseldorf, Germany; Hospital Universitario La Fe, Valencia, Spain; Peter MacCallum Cancer Centre and University of Melbourne, Melbourne,... Department of Haematology, Oncology and Clinical Immunology Medical Faculty University of Düsseldorf Düsseldorf Germany Department of Hematology, Oncology and Clinical Immunology, Heinrich Heine University, Düsseldorf, Germany Department of Hematology, Oncology, and Clinical Immunology, Heinrich-Heine-University, Düsseldorf, Germany Department Of Haematology, Oncology and Clinical Immunology Universitätsklinik Düsseldorf Düsseldorf Germany Universitätsklinikum Düsseldorf, Düsseldorf, Germany |
Incoming Links
Total number of triples: 397.